Professor Yamanaka’s research aims to standardize iPSC technology for the preparation of clinical grade iPSCs by providing clear guidelines for cell sources and induction factors, along with reliable methods for quality control. iPSC studies have recently shown major progress in conditions, including corneal disease, blood diseases and Parkinson’s disease, suggesting more iPSC-based regenerative medicine in the future.
Professor Louis J. Ignarro on "The Unique Role of Nitric Oxide As a Signaling Molecule"
19 Sep, 2006